In breast, bladder, and pancreatic cancer and other malignant tumors, targeting the glycolysis pathway mediated by PFKFB4 can inhibit the growth and invasion of tumor cells (Zhang et al., 2016; Dasgupta et al., 2018; Zhang et al., 2021b). The gene discussed is PFKFB4; the disease is neoplasm.